Skip to main navigation Skip to search Skip to main content

Pharmaceutical waste management through microbial bioremediation

Research output: Contribution to journalReview articlepeer-review

Abstract

Pharmaceuticals play a significant role in enhancing the quality of life. However, pharmaceutical products (PPs) manufacturing presents challenges, particularly in terms of waste generated, posing a risk to the ecosystem. Existing physical and chemical remediation methods are expensive and are not directly applicable for pharmaceutical remediation. Bioremediation using various microbial consortia has the potential to become a cost-effective solution when applied optimally. This review highlights the various pharmaceutical products, their occurrence in the environment, and their associated health risks. Further, various microorganisms employed in the bioremediation process and the techniques utilized to degrade diverse categories of pharmaceutical pollutants are discussed. Finally, the review highlights the limitations of using bioremediation for treating pharmaceutical waste and discusses alternative sustainable green pharmacy approaches to reduce the impact of pharmaceutical contaminants on the environment.

Original languageEnglish
Article number488
JournalEnvironmental Monitoring and Assessment
Volume197
Issue number4
DOIs
Publication statusPublished - 04-2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • General Environmental Science
  • Pollution
  • Management, Monitoring, Policy and Law

Fingerprint

Dive into the research topics of 'Pharmaceutical waste management through microbial bioremediation'. Together they form a unique fingerprint.

Cite this